Topical Intra-Oral Ketoprofen for Migraine Prevention

Completed · Phase 3 · Has a placebo group

Conditions studied: Migraine

In brief

Intra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been shown to prevent migraines when used once daily for 3 months in open label studies. This is a randomized, double-blind, placebo controlled phase III prevention trial to determine safety and efficacy.

Key facts

Study ID

NCT01211795

Run by

Behar, Caren, M.D.

People needed

67

Starts

2009-10-01

Expected to finish

2011-06-01

Last updated by the study team

2011-06-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• IHS Migraine with or without aura
• 18 y.o. or older
• at least 4 migraines per month

You may not qualify if…

• pregnancy
• other headache conditions
• chronic daily headache
• allergy or sensitivity to NSAIDs other severe illnesses

Where it is running

• New York Medical College — Valhalla, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.